Flunisolide Spray Rx
Generic Name and Formulations:
Flunisolide 25mcg/spray; nasal soln.
Various generic manufacturers
Indications for Flunisolide Spray:
Seasonal or perennial rhinitis.
≥15yrs: Initially 2 sprays in each nostril twice daily; max 8 sprays/nostril per day.
<6yrs: not recommended. 6–14yrs: Initially 1 spray in each nostril 3 times daily or 2 sprays twice daily; max 4 sprays/nostril per day.
Untreated nasal infections.
Maintain regular regimen. Respiratory tract tuberculosis. Infections (eg, ocular herpes simplex). If exposed to measles or chickenpox, consider anti-infective prophylactic therapy. Reduce dose as condition improves. May use nasal decongestants if needed. Discontinue if no effect after 3 wks. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with topical corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, depression). Monitor for growth suppression in children. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually), and candida infection or other nasal mucosal changes. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.
Nasal discomfort, congestion, sneezing, epistaxis, lacrimation, sore throat, nausea, headache, loss of taste and smell, septal perforation, hypercorticism, fungal overgrowth, impaired wound healing, glaucoma, reduced growth velocity in children.
Formerly known under the brand names Nasalide, Nasarel.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Qualitative Analysis of Myeloma Patients' Experience Following Hematopoietic Stem Cell Transplant
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
- Patient Fears of Placebo Use in Clinical Trials
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|